Introduction to Cancer Metastasis
113,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
57 °P sammeln
  • Gebundenes Buch

Introduction to Cancer Metastasis provides, in one place, an overview of organ-specific cancer metastasis and the most common sites of cancer metastasis. Through specific chapters on individual primary cancers, their metastasis, and chapters on common metastatic sites, this volume comprehensively informs readers about the broader knowledge base in cancer metastasis. The process of metastasis is particularly responsible for making cancer so lethal. This volume explores both metastasis from sites of origin and common metastatic sites, thus increasing understanding of both perspectives.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Introduction to Cancer Metastasis provides, in one place, an overview of organ-specific cancer metastasis and the most common sites of cancer metastasis. Through specific chapters on individual primary cancers, their metastasis, and chapters on common metastatic sites, this volume comprehensively informs readers about the broader knowledge base in cancer metastasis. The process of metastasis is particularly responsible for making cancer so lethal. This volume explores both metastasis from sites of origin and common metastatic sites, thus increasing understanding of both perspectives.
Autorenporträt
Prof. Aamir Ahmad, PhD is a distinguished cancer experimenter, Experienced Scientist and Group Leader of Epigenetics Research at the Translational Research Institute, Hamad Medical Corporation, Qatar. With expansive experience in oncology, epigenetics, and translational drug, he has held crucial academic and exploration positions at institutions like the University of Alabama at Birmingham, University of South Alabama, and Wayne State University. Prof. Ahmad's work focuses on cancer epigenetics, medicine resistance, and tumor microenvironment, with over 250 peer reviewed publications, 20,000 citations and an h- indicator of 69. honored among the top 2 of scientists for career-long impact, he serves as Editor- in- Chief of Non-coding RNA exploration and leads multiple funded systems on cancer therapeutics. A plentiful author, speaker, and grant critic, his patronages have shaped advancements in perfection drug and targeted therapeutic regimes for cancer.